Cutting-edge Neuromodulation Tackles Disease on All Fronts

With the neuromodulation market surpassing $7B by 2025, the mysteries behind this med tech are revealed. Hear from industry leaders how this emerging technology is tackling everything from chronic pain, Parkinson’s and sleep apnea to epilepsy, paralysis, stroke, incontinence and depression.

Wednesday, January 8

4:35 – 5:00 PM

LOCATION Venetian Level 4 Lando 4305

All CES conference sessions are seated on a first-come, first-served basis.